BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.31B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$872M |
| 3 |
State Street SPDR S&P Biotech ETF
XBI
|
+$311M |
| 4 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$169M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$169M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Gold Miners ETF
GDX
|
+$169M |
| 2 |
CELG
Celgene Corp
CELG
|
+$148M |
| 3 |
iShares MSCI Japan ETF
EWJ
|
+$134M |
| 4 |
State Street SPDR S&P Retail ETF
XRT
|
+$121M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$83.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.92% |
| 2 | Financials | 6.08% |
| 3 | Healthcare | 5.28% |
| 4 | Consumer Discretionary | 5.21% |
| 5 | Communication Services | 4.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2901
Koppers
KOP
$894M
| $121K | ﹤0.01% |
4,639
+3,833
| +476% | +$90.1K |
|
|
SRDX
2902
DELISTED
Surmodics
SRDX
| $120K | ﹤0.01% |
2,762
+2,528
| +1,080% | +$129K |
|
2903
Great Southern Bancorp
GSBC
$889M
| $120K | ﹤0.01% |
2,313
+1,624
| +236% | +$86.2K |
|
|
PFC
2904
DELISTED
Premier Financial Corp. Common Stock
PFC
| $120K | ﹤0.01% |
4,175
+3,313
| +384% | +$95.6K |
|
|
SPTN
2905
DELISTED
SpartanNash
SPTN
| $120K | ﹤0.01% |
7,540
+4,205
| +126% | +$80.7K |
|
|
EIGI
2906
DELISTED
Endurance International Group Holdings, Inc.
EIGI
| $120K | ﹤0.01% |
16,500
+14,588
| +763% | +$106K |
|
2907
Team
TISI
$101M
| $120K | ﹤0.01% |
683
+435
| +175% | +$68.9K |
|
|
CBLK
2908
DELISTED
Carbon Black, Inc. Common Stock
CBLK
| $119K | ﹤0.01% |
8,541
+8,079
| +1,749% | +$115K |
|
2909
Par Pacific Holdings
PARR
$4.03B
| $119K | ﹤0.01% |
6,671
+6,659
| +55,492% | +$110K |
|
2910
Veeco
VECO
$3.19B
| $119K | ﹤0.01% |
10,948
+2,280
| +26% | +$23.5K |
|
2911
Timken Company
TKR
$9.25B
| $119K | ﹤0.01% |
2,717
-27,662
| -91% | -$1.18M |
|
2912
St. Joe Company
JOE
$3.89B
| $118K | ﹤0.01% |
7,183
+4,112
| +134% | +$63.3K |
|
2913
Energizer
ENR
$1.56B
| $118K | ﹤0.01% |
2,631
-1,260
| -32% | -$58.1K |
|
2914
Vicor
VICR
$10.7B
| $118K | ﹤0.01% |
3,810
+3,600
| +1,714% | +$133K |
|
2915
ANI Pharmaceuticals
ANIP
$1.75B
| $118K | ﹤0.01% |
1,667
+1,664
| +55,467% | +$97.9K |
|
|
CTRL
2916
DELISTED
Control4 Corporation
CTRL
| $117K | ﹤0.01% |
6,937
+4,561
| +192% | +$82.3K |
|
2917
KLX Energy Services
KLXE
$36M
| $117K | ﹤0.01% |
932
+664
| +248% | +$88K |
|
|
CWEN.A
2918
DELISTED
Clearway Energy Class A
CWEN.A
| $117K | ﹤0.01% |
8,031
+5,312
| +195% | +$77.7K |
|
2919
Forrester Research
FORR
$218M
| $117K | ﹤0.01% |
2,415
+2,183
| +941% | +$102K |
|
|
NVEE
2920
DELISTED
NV5 Global
NVEE
| $117K | ﹤0.01% |
7,860
+7,848
| +65,400% | +$135K |
|
2921
TTEC Holdings
TTEC
$77.4M
| $117K | ﹤0.01% |
3,216
+2,692
| +514% | +$90.9K |
|
2922
MYR Group
MYRG
$5.22B
| $116K | ﹤0.01% |
3,360
+2,939
| +698% | +$95.6K |
|
|
SRNE
2923
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $116K | ﹤0.01% |
+24,418
| New | +$64.1K |
|
2924
Bank of Marin Bancorp
BMRC
$457M
| $116K | ﹤0.01% |
2,849
+2,060
| +261% | +$87.6K |
|
2925
Nu Skin
NUS
$235M
| $116K | ﹤0.01% |
2,418
+1,369
| +131% | +$83K |
|
Similar funds
BNP Paribas Financial Markets's Q1 2019 Portfolio in Review
As of Q1 2019, BNP Paribas Financial Markets held 4,541 positions worth $46.3B, up 9.3% from $42.3B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
BNP Paribas Financial Markets deployed $4.24B of net new capital in Q1 2019, opening 207 new positions and adding to 2,771 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 649,500 shares worth $128M.
By sector, the portfolio is most concentrated in Technology at 7.9% of assets, up from 7.1% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was VanEck Gold Miners ETF, an estimated $169M trimmed.
- BNP Paribas Financial Markets's largest Q1 2019 buy was iShares Russell 2000 Growth ETF: 649,500 shares worth $128M.
- BNP Paribas Financial Markets added most to Invesco QQQ Trust in Q1 2019, an estimated $1.31B increase.
- BNP Paribas Financial Markets's biggest Q1 2019 reduction was VanEck Gold Miners ETF, cutting an estimated $169M.
- BNP Paribas Financial Markets fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $37.8M.
- BNP Paribas Financial Markets's ten largest holdings make up 17% of its $46.3B portfolio in Q1 2019.
- BNP Paribas Financial Markets opened 207 new positions and closed 255 in Q1 2019.
- BNP Paribas Financial Markets's portfolio value rose 9.3% quarter-over-quarter to $46.3B.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2019, filed 25 Apr 2019.